{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:45:16Z","timestamp":1768686316570,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.semarthrit.2018.09.008","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T05:51:38Z","timestamp":1538113898000},"page":"558-562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Therapeutic tolerance in autoimmune disease"],"prefix":"10.1016","volume":"48","author":[{"given":"Fiona","family":"Rayner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semarthrit.2018.09.008_bib0001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.0990109","article-title":"Actively acquired tolerance\u2019 of foreign cells","volume":"184","author":"Billingham","year":"1953","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2018.09.008_bib0002","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fimmu.2012.00254","article-title":"Translating tolerogenic therapies to the clinic \u2013 where do we stand","volume":"3","author":"Issa","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2018.09.008_bib0003","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.16.1.619","article-title":"How do monoclonal antibodies induce tolerance? A role for infectious tolerance","volume":"16","author":"Waldmann","year":"1998","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2018.09.008_bib0004","first-page":"419","article-title":"CD4 antibody therapy in systemic lupus erythematosus","volume":"2","author":"Wofsy","year":"1990","journal-title":"Semin Immunol"},{"issue":"4","key":"10.1016\/j.semarthrit.2018.09.008_bib0005","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MOT.0000000000000207","article-title":"Tolerance signatures in transplant recipients","volume":"20","author":"Newell","year":"2015","journal-title":"Curr Opin Organ Transpl"},{"issue":"8","key":"10.1016\/j.semarthrit.2018.09.008_bib0006","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/annrheumdis-2016-209201","article-title":"Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions","volume":"75","author":"Schett","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2018.09.008_bib0007","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nrrheum.2017.200","article-title":"The RA-MAP consortium: a working model for academia-industry collaboration","volume":"14","author":"Cope","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2018.09.008_bib0008","first-page":"299","article-title":"A pilot study of combination anti-cytokine and anti-lymphocyte biological therapy in rheumatoid arthritis","volume":"101","author":"Morgan","year":"2008","journal-title":"QJM Mon J Assoc Phys"},{"issue":"4","key":"10.1016\/j.semarthrit.2018.09.008_bib0009","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.berh.2010.01.007","article-title":"Treating to re-establish tolerance in inflammatory arthritis \u2013 lessons from other diseases","volume":"24","author":"Cooles","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2018.09.008_bib0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/BOR.0000000000000029","article-title":"Prospects for therapeutic tolerance in humans","volume":"26","author":"Baker","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2018.09.008_bib0011","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clim.2013.05.001","article-title":"Anti-CD3 clinical trials in type 1 diabetes mellitus","volume":"149","author":"Daifotis","year":"2013","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.semarthrit.2018.09.008_bib0012","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/ard.2009.119016","article-title":"Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)","volume":"69","author":"Emery","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2018.09.008_bib0013","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.berh.2013.09.001","article-title":"Early rheumatoid arthritis: the performance of the 2010 ACR\/EULAR criteria for diagnosing RA","volume":"27","author":"Mjaavatten","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.09.008_bib0014","unstructured":"Available from: https:\/\/www.kcl.ac.uk\/lsm\/research\/divisions\/diiid\/departments\/rheumatology\/research\/clinical\/current\/apippra\/apippra.aspx."},{"key":"10.1016\/j.semarthrit.2018.09.008_bib0015","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3389\/fimmu.2018.00392","article-title":"Peptide Immunotherapy for Type 1 diabetes-clinical advances","volume":"9","author":"Smith","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2018.09.008_bib0016","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"290","key":"10.1016\/j.semarthrit.2018.09.008_bib0017","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci Transl Med"},{"issue":"315","key":"10.1016\/j.semarthrit.2018.09.008_bib0018","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"issue":"22","key":"10.1016\/j.semarthrit.2018.09.008_bib0019","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2018.09.008_bib0020","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/annrheumdis-2014-206506","article-title":"Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE","volume":"74","author":"Humrich","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.09.008_bib0021","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.4148","article-title":"Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus","volume":"22","author":"He","year":"2016","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2018.09.008_bib0022","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"New Engl J Med"},{"issue":"10075","key":"10.1016\/j.semarthrit.2018.09.008_bib0023","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.semarthrit.2018.09.008_bib0024","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1182\/blood-2002-03-0671","article-title":"Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis","volume":"100","author":"Ponchel","year":"2002","journal-title":"Blood"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218305997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218305997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T22:13:52Z","timestamp":1560377632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017218305997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0049017218305997"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.09.008","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic tolerance in autoimmune disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}